Alzheimer’s Disease May begin decades before the first symptoms APPEAR1
About ID/AD
Alzheimer's disease (AD) represents a significant unmet medical need and a growing global health challenge.
The ID/AD initiative – Identify (ID) Alzheimer’s Disease (AD) aims to raise awareness of Alzheimer’s disease early signs and symptoms and the importance of accurate diagnosis for timely brain health interventions.
Defining Alzheimer’s Disease
A better understanding of the early stages of Alzheimer's disease is opening up opportunities for early detection, diagnosis and interventions.
Early Detection & Diagnosis
Early detection of mild cognitive impairment provides an opportunity to identify Alzheimer’s patients in the pre-dementia stage.
Mild cognitive impairment (MCI) due to Alzheimer's disease (AD) is one of the earliest stages of the disease.2 Early detection matters.3
Early Intervention
Overcoming Barriers for an Early Alzheimer’s Disease Diagnosis
learn more
Collaboration among all stakeholders is required to improve Alzheimer's prevention, diagnosis, and care.
Early Intervention Matters
learn more
Close collaboration between primary and specialized care is needed to improve Alzheimer's disease management.
Brain Health
learn more
Lifestyle interventions, including social and cognitive activity, may help preserve brain health.
Alzheimer's Disease:
The Silent Epidemic
Policy leadership and commitment is needed in Alzheimer's disease to optimise quality of care and support for patients, their caregivers and families.
Resources
Find useful resources for clinical practice including links to journal articles, selected information on Alzheimer's disease, ideas for patient engagement and insights into AD health research initiatives.
References
1.Alzheimer’s Association. Alzheimer’s Association Report: 2020 Alzheimer’s disease facts and figures. Alzheimer’s Dement. 2020;16(3):391-460.
2.Petersen RC. Mild cognitive impairment. Continuum (Minneap Minn). 2016;22(2):404-418.
3.Dubois B, Padovani A, Scheltens P, et al. Timely Diagnosis for Alzheimer's Disease: A Literature Review on Benefits and Challenges. J Alzheimers Dis. 2016;49(3):617-31.